跳至主要内容
临床试验/TCTR20220215001
TCTR20220215001Enrolling By Invitation2 期

A study of therapeutic equivalence of mometasone lotion and Elomet lotion in seborrheic dermatitis of scalp

HOE Pharmaceuticals Sdn. Bhd.0 个研究点目标入组 100 人开始时间: 2022年2月15日最近更新:
适应症

试验速览

阶段
2 期
状态
Enrolling By Invitation
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Age 18-80 years
  • 2. Diagnosed with seborrheic dermatitis of scalp
  • 3. New onset dermatitis or recurrent seborrheic dermatitis in which can withdraw topical steroid and Moisturizer for 2 weeks, oral medication for 4 weeks before joining this project
  • 4.No other medications usage during the project
  • 5.Can follow up at 2nd and 4th week of the project
  • 6. Inform and consent

排除标准

  • 1. History of allergic reaction to component used in the project
  • 2. Ongoing bacterial, fungal or viral skin infection
  • 3. Pregnancy or breastfeeding
  • 4. History of allergic reaction to topical or systemic steroid
  • 5. Deny or withdraw during attending the project

研究者

相似试验